15 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

OPDIMA

FDA 510(k)
FDA Class 2 ·Radiology

N/A

FDA UDI
MEDTRONIC SOFAMOR DANEK, INC.·00643169328792·TEMPLATE 3003945 ZEVO 45MM 3 LVL

SYNTHES (USA) MEDIAL DISTAL TIBIA PLATES

FDA 510(k)
FDA Class 2 ·Orthopedic

PARA 12 PLUS RETICS

FDA 510(k)
FDA Class 2 ·Hematology

SECURE FLOW

FDA Adverse Event
Injury ·WOO YOUNG MEDICAL INC.·Product code MEB·March 27, 2012

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·March 14, 2013

TRILOGY ACE SYSTEM

FDA Adverse Event
Injury ·ZIMMER RANDALL ASSOC·Product code KWZ·February 23, 2011

2250051-2008-00064

FDA Adverse Event
Malfunction ·Product code JTC·February 1, 2008

APTIMA SARS-COV-2 ASSAY

FDA Adverse Event
Malfunction ·HOLOGIC INCORPORATED·Product code QJR·August 3, 2022

APTIMA SARS-COV-2 ASSAY

FDA Adverse Event
Malfunction ·HOLOGIC INCORPORATED·Product code QJR·August 3, 2022

APTIMA SARS-COV-2 ASSAY

FDA Adverse Event
Malfunction ·HOLOGIC INCORPORATED·Product code QJR·August 3, 2022

APTIMA SARS-COV-2 ASSAY

FDA Adverse Event
Malfunction ·HOLOGIC INCORPORATED·Product code QJR·August 3, 2022

UUltrasound System 2300, bkActiv w/battery; Model No. 2300-11; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic

FDA Enforcement
Class II ·Ongoing·B-K Medical A/S·November 12, 2025

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024